Decrease in androgen binding and effect of androgen treatment in a case of X-linked bulbospinal neuronopathy.

Danek, A; Witt, T N; Mann, K; Schweikert, H U; Romalo, G; La Spada, A R; Fischbeck, K H

Danek, A; Witt, T N; Mann, K; Schweikert, H U; Romalo, G; La Spada, A R; Fischbeck, K H.

Affiliation

Danek A; Neurologische Klinik, Ludwig-Maximilians-Universität, München, Germany.

Clin Investig ; 72(11): 892-7, 1994 Nov.

Article in En | MEDLINE | ID: mdl-7894219

Subject(s)

Anabolic Agents/therapeutic use; Motor Neuron Disease/drug therapy; Muscular Atrophy, Spinal/drug therapy; Nandrolone/analogs & derivatives; Follow-Up Studies; Genetic Linkage; Humans; Male; Middle Aged; Motor Neuron Disease/genetics; Motor Neuron Disease/metabolism; Muscular Atrophy, Spinal/genetics; Nandrolone/therapeutic use; Nandrolone Decanoate; Receptors, Androgen/metabolism; X Chromosome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Muscular Atrophy, Spinal / Motor Neuron Disease / Anabolic Agents / Nandrolone Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male / Middle aged Language: En Journal: Clin Investig Journal subject: MEDICINA Year: 1994 Document type: Article Affiliation country: Germany Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links